Previous 10 | Next 10 |
2023-09-14 08:35:46 ET More on Charles River Seeking Alpha’s Quant Rating on Charles River Laboratories Historical earnings data for Charles River Laboratories Financial information for Charles River Laboratories Charles River Laboratories Internationa...
Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences (“RS”), a data science-...
NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical sensitivity Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest SAS, a leader in the development and provision of next-generation sequencing (NGS) test...
2023-08-29 00:42:16 ET Summary Ariel Investments' 13F portfolio value increased by 2% to $10.56B in Q2 2023. The portfolio is diversified with around 150 positions, with the largest stakes in Baidu, Mattel, Philip Morris, Kennametal, and Generac Holdings. The Ariel Fund has a ...
2023-08-24 08:47:31 ET More on Charles River Laboratories Charles River Laboratories International, Inc. ( CRL ) Q2 2023 Earnings Call Transcript Charles River Laboratories International, Inc. 2023 Q2 - Results - Earnings Call Presentation Charles River Laborator...
HQ pDNA will be used to produce GMP lentivirus for ex vivo gene therapy Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River...
2023-08-21 09:48:10 ET More on Phathom Pharmaceuticals Phathom Pharma: Time To Take Profits (Rating Downgrade) Phathom resubmits vonoprazan application for esophagitis to FDA, announces stock offering Phathom gains as Evercore ISI upgrades on potential vonoprazan app...
2023-08-18 18:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-09 14:32:07 ET Charles River Laboratories International, Inc. (CRL) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 AM ET Company Participants Todd Spencer - Vice President, Investor Relations Jim Foster - Chairman, President and Chief Executive Offic...
2023-08-09 07:07:03 ET Charles River Laboratories press release ( NYSE: CRL ): Q2 Non-GAAP EPS of $2.69 beats by $0.05 . Revenue of $1.06B (+8.9% Y/Y) beats by $10M . The Company’s 2023 guidance for revenue growth and earnings per share is as follows ...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics Under the agreement, Charles River will make an equity investment in Aut...
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 7 th , at 9:00 a.m. ET. Investors wi...
Critical starting material manufacture for therapeutic targeting high unmet need ophthalmology indication Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agreement to produce Good...